3D Skin Models Offer New Window Into Microbiome of Chronic Wounds

Researchers have developed three-dimensional (3D) skin models specifically designed to study how the skin microbiome interacts with immune cells in chronic wounds — a pairing that standard two-dimensional cell culture and animal models have long failed to reproduce with clinical fidelity.

The work, published in Cureus, addresses a stubborn translational gap in wound-care research. Chronic wounds — diabetic foot ulcers, venous leg ulcers, pressure injuries — are estimated to affect millions of patients worldwide, yet the cellular conversation between resident microbes and infiltrating immune cells remains poorly mapped, largely because researchers have lacked a platform that keeps both parties alive and behaving as they do in human tissue.

Why 3D models, and why now?

A flat dish of keratinocytes doesn't answer the question clinicians actually ask: why does a wound stall in an inflammatory state for months? Animal skin differs from human skin in microbiome composition, immune-cell repertoire and healing kinetics, which limits how cleanly mouse data transfer to the clinic.

A 3D skin model layers the architecture of the epidermis and dermis, and — crucially for this application — can be colonized with defined microbial communities and seeded with immune cells. That gives researchers a controllable system in which they can perturb one variable at a time: add a suspected pathogen, remove an immune-cell subtype, change the oxygen tension, and watch what happens to the tissue.

The Cureus paper walks through the design considerations for building such models for chronic-wound research specifically, where the goal is not pristine barrier function but a reproducibly inflamed, slow-to-heal environment.

What does this change for dermatology research?

For investigators, it moves chronic-wound microbiome studies from correlation toward mechanism. Sequencing surveys have shown dysbiotic communities in non-healing wounds, but they can't establish causation — you can't tell from a swab whether Staphylococcus is driving inflammation or simply thriving in it. A colonized 3D model lets researchers test that directionality directly.

For clinicians, the downstream payoff is target identification: which microbial factors sustain the inflammatory loop that keeps a wound open, and which immune responses could be modulated without compromising infection defense. That's the kind of question the platform is built to answer before any therapy reaches a patient cohort.

The authors position the approach as a bridge — one that could reduce reliance on animal models while producing data that maps more directly onto human wound biology. As with any in vitro system, the models remain simplifications, and validation against patient-derived samples will determine how far findings carry.

Looking ahead, the platform sets the stage for testing microbiome-targeted and immunomodulatory wound therapies on human-like tissue before committing to costly clinical trials.